Skip to main content
Signal8

LIERMAN TERRY L

SEC insider (Form 3/4/5 filer). CIK 0002014677. Director at IGC Pharma, Inc. (IGC). 1 reported Form 4/5 transaction since Sep 2024; latest on Oct 17, 2025. Located in POTOMAC, MD.

Companies LIERMAN TERRY L has filed insider reports for

  • IGC Pharma, Inc. (IGC): Director
LIERMAN TERRY L profile photo

LIERMAN TERRY L

CIK: 0002014677

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IGC Pharma, Inc. logo
IGC

IGC Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • IGC Pharma, Inc. logo
    IGC

    IGC Pharma, Inc.

    Oct 17, 2025
    Award

    Options

    Direct
    500K shares-

1-1 of 1